New President and CEO of AddLife

AddLife 01/09/2022

We are excited to announce, that as of today, we have a new CEO, Fredrik Dalborg. Fredrik is succeeding Kristina Willgård, our former CEO of seven successful years since AddLife started.

Fredrik Dalborg Linkedin

Fredrik joins us from his most recent role as Managing director of North America of XVIVO Perfusion. Fredrik is a well-qualified and business-oriented leader with international experience deeply rooted in Life Science.

“I have followed AddLife with great interest and am impressed with what the team has achieved under Kristina's leadership. The corporate culture and management philosophy that AddLife stands for is in line with my values and I am happy to be part of the AddLife team”, says Fredrik Dalborg, CEO of AddLife

We welcome Fredrik and look forward to working with him!

News from AddLife’s subsidiaries

Euroclone Q4 2023
02 February 2024
Euroclone serves science through innovation

Euroclone´s mission is to serve science through innovation. This is represented by searching around the globe all innovation available in the market that represents new frontiers for Biomedical research.

Euroclone
Sailab Carita Eriikka Jussi 2024 768X403
22 January 2024
Association supporting healthcare

Sailab – MedTech Finland is an association that, together with its member companies, helps the Finnish healthcare system produce the best treatment solutions.

triolab oy